Related Experiment Video

Updated: Jun 25, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

[Immune mechanisms of inflammation in dilated cardiomyopathy]

S N Tatenkulova, V Iu Mareev, K A Zykov

    Kardiologiia
    |March 4, 2009
    PubMed

    Insights

    Inflammation plays a key role in dilated cardiomyopathy (DCM), with elevated inflammatory markers linked to disease severity and complications like arrhythmias and diastolic dysfunction.

    Area of Science:

    • Cardiology
    • Immunology
    • Biochemistry

    Background:

    • Dilated cardiomyopathy (DCM) is a complex condition with significant inflammatory components.
    • Understanding the immune mechanisms underlying DCM is crucial for developing targeted therapies.

    Purpose of the Study:

    • To investigate the immune mechanisms of inflammation in patients with dilated cardiomyopathy (DCM).
    • To correlate inflammatory markers with disease severity and complications in DCM.

    Main Methods:

    • Studied 44 DCM patients (NYHA FC I-IV), assessing C-reactive protein (CRP), immunoglobulins (IgG, IgA, IgM), and cytokines (Il-6, Il-18, Il-10, sIl-2R, Il-8, IFN-gamma).
    • Utilized nephelometry for CRP and immunoglobulins, and immunoenzyme analysis for cytokines.
    • Echocardiography (EchoCG) assessed left ventricular (LV) systolic and diastolic function.

    Main Results:

    • Elevated CRP, sIl-2R, and Il-8 levels were observed in DCM patients, indicating an inflammatory process.
    • Patients with arrhythmias showed elevated IFN-gamma and CRP, suggesting a Th-1 type inflammatory response.
    • Diastolic dysfunction in DCM was linked to inflammation, with IFN-gamma correlating with diastolic time (DT) and Il-6 elevated in restrictive diastolic dysfunction.

    Conclusions:

    • Increased pro-inflammatory factors confirm an inflammatory process in DCM.
    • Elevated inflammatory mediators are associated with disease complications, including arrhythmias, worsening heart failure class, and impaired diastolic function.
    Abstract

    More Related Videos

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    Related Concept Videos

    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Myocarditis II: Clinical Features and Diagnostic Tests01:27

    Myocarditis II: Clinical Features and Diagnostic Tests

    Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...